In line with the RBM study discussed above, our own earlier study found increased CSF C3 and FH levels in AD patients compared with CN subjects, as well as significant negative correlations between the two complement biomarkers and MMSE scores [41]. The gene discussed is C3; the disease is Alzheimer disease.